Showing results (941-950 of 996) with videos related to

Sort By:
Pageof 100
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2021
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research GroupRoisin M Connolly, Fengmin Zhao, Kathy D Miller, et al.
NPJ Breast Cancer|October 12, 2019
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B Page, Harry Bear, Sangeetha Prabhakaran, et al.
Clinical Breast Cancer|June 5, 2019
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 StudyDenise A Yardley, Lowell Hart, Anne Favret, et al.
NPJ Breast Cancer|January 6, 2026
Racial disparity in pro-metastatic tumor microenvironment in treatment naïve breast cancerPriyanka Parmar, Burcu Karadal-Ferrena, Suryansh Shukla, et al.
Journal of the National Cancer Institute|May 3, 2018
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast CancerJinani Jayasekera, Yisheng Li, Clyde B Schechter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast CancerBryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Frontiers in Immunology|May 4, 2026
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world studyFrancesco Caraglia, Giuseppe Argenziano, Marcella Scala, et al.
NEJM Evidence|July 23, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and SurvivalJoseph A Sparano, Michael Crager, Robert J Gray, et al.
Cancer Research Communications|July 17, 2026
Development and Validation of a Multimodal-Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast CancerEleftherios P Mamounas, Ming Chen, Joseph A Sparano, et al.
Pageof 100